Trade

Trade Biosciences is a biotechnology company focused on the discovery and development of novel small molecule therapeutics targeting G protein-coupled receptors (GPCRs). The company utilizes its proprietary Trade Platform to identify and optimize drug candidates for a variety of indications, including metabolic diseases, inflammation, and neurological disorders. By leveraging advanced computational and experimental techniques, Trade Biosciences aims to address unmet medical needs through the modulation of GPCR signaling pathways. The company's pipeline is currently in the pre-clinical stage, with several programs undergoing lead optimization and validation.